960000.00
1200000.00
Inclusive of all taxes
You Save: 240000. Discount 20%
Product is not available
Docetaxel anhydrous is a potent anti-cancer drug used primarily in chemotherapy for breast, lung, and prostate cancers. It functions by inhibiting microtubule depolymerization, disrupting cell division. Manufactured under strict GMP guidelines, this API is used in the formulation of injectable solutions. Its anhydrous form offers superior stability and purity for medical applications.
Docetaxel is a semi-synthetic chemotherapeutic agent belonging to the taxane family, primarily used in the treatment of various cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer. It is derived from a precursor found in the needles of the European yew tree (Taxus baccata). Docetaxel works by inhibiting cell division through the stabilization of microtubules, preventing their disassembly, which is essential for mitosis.
Product Summary:
CAS Number: 114977-28-5
Molecular Formula: C43H53NO14
Molecular Weight: 807.88 g/mol
Synonyms: Taxotere
Packaging: As per regulatory requirements (usually 1–10 g vials)
Solubility: Soluble in ethanol and polysorbates
Storage: Refrigerated; protect from light
Toxicity: Cytotoxic; handle with gloves and in sterile conditions
Applications:
Oncology – breast, lung, prostate cancers
Chemotherapeutic API
Research in cancer biology
